Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

FMED vs TMAT: Holdings Overlap & Returns

Share
Share on XDownload as PDF

Over the year to Nov 4, 2026, FMED returned +27.4% to TMAT's −3.1%; 3% of their weight is in the same names.

askIQ about this page

askIQ about FMED and TMAT

Net assets: $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF, and $237m on Jul 31, 2026 for Main Thematic Innovation ETF.

At a glance
21.8%
FMED in the S&P 500
50.3%
TMAT in the S&P 500
+27.4%
FMED total return, 1 year
−3.1%
TMAT total return, 1 year
FMED · 1 year to Nov 4, 2026 78% of its weight is outside the S&P 500
78% of its weight is outside the S&P 50022% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.22%78%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 33% of the fund · 72 holdings as filed for Aug 31, 2026 · Nasdaq-100: 5% in78% of its weight is outside the S&P 50022% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.22%78%inoutside the S&P 500active share 98% · Nasdaq-100: 5% in

22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.

TMAT · 1 year to Nov 4, 2026 50% of its weight is outside the S&P 500
50% of its weight is outside the S&P 50050% of TMAT's weight is in S&P 500 companies and 50% is outside the index. Holdings as of Jul 31, 2026.50%50%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 92% · top ten 27% of the fund · 87 holdings as filed for Jul 31, 2026 · Nasdaq-100: 29% in50% of its weight is outside the S&P 50050% of TMAT's weight is in S&P 500 companies and 50% is outside the index. Holdings as of Jul 31, 2026.50%50%in the S&P 500outside the S&P 500active share 92% · Nasdaq-100: 29% in

50% of TMAT's weight is in S&P 500 companies and 50% is outside the index. Holdings as of Jul 31, 2026.

Pair scorecard

FMED costs 0.29 points a year less; their one-year returns differ by 30.5 points.

Points (pts) are percentage points.

FMED vs TMAT: Holdings Overlap & Returns
MeasureFMEDTMAT
Return
Total return, 1 year+27.4%−3.1%
Drawdown
Below its all-time high15.9%, high on Jun 30, 2026
Against its benchmark
What it tracksBroad innovation and megatrendsBroad innovation and megatrends
Its benchmark, total return, 1 year+15.0%
Against its benchmark, 1 yearbehind by 18.1 pts
Cost and size
Expense ratio0.50%0.79%
Net assets, FMED as of Sep 30, 2026 and TMAT as of Jul 31, 2026$52m$237m
Holdings
Holdings in common3%

Method

What they share

3%

By the books each fund has filed, FMED and TMAT hold 3% of their money in the same securities at the same weight. Holdings dated Jul 31, 2026 and Aug 31, 2026.

0 half 100%

half

3% in common

Positions both hold · largest shared weight first FMED TMAT
VERACYTE INC 1.01% 1.30%
VEEVA SYS INC 1.66% 0.88%
DEXCOM INC 0.71% 0.66%
WAYSTAR HOLDING CORP 0.91% 0.34%
INTUITIVE SURGICAL INC 2.05% 0.25%
Only in one fund ↓
Only in FMED
10X GENOMICS INC 5.19%
THERMO FISHER SCIENTIFIC INC 3.83%
DANAHER CORP 3.73%
NATERA INC 3.30%
ARGENX SE 3.20%
LIFESTANCE HEALTH GROUP INC 3.00%
REVOLUTION MEDICINES INC 2.87%
ILLUMINA INC 2.82%
Only in TMAT
PALO ALTO NETWORKS INC 4.46%
MICRON TECHNOLOGY INC 4.23%
CROWDSTRIKE HOLDINGS INC 2.77%
FORTINET INC 2.63%
CLEAR SECURE INC 2.43%
VICOR CORP 2.18%
HINGE HEALTH INC 2.09%
LUMENTUM HOLDINGS INC 2.06%
Check overlap with more funds →

Window by window

Window by window: FMED vs TMAT: Holdings Overlap & Returns
Total returnvs its benchmark
WindowFMEDTMATFMEDTMAT
3 months+14.9%−9.4%not measured−8.1 pts vs ACWI
6 months+31.2%−4.9%not measured−7.5 pts vs ACWI
1 year+27.4%−3.1%not measured−18.1 pts vs ACWI
3 years+57.8%+92.3%not measured+14.7 pts vs ACWI
Since launchNot the same days: FMED Jun 2023 · TMAT Jan 2021+31.7%+7.5%not measured−85.1 pts vs ACWI

Open this comparison in the app →

Side by side

FMED Fidelity Disruptive Medicine ETF · Holds 72 stocks in broad innovation and megatrends, 22% of its weight in S&P 500 companies TMAT Main Thematic Innovation ETF · Holds 87 stocks in broad innovation and megatrends, 50% of its weight in S&P 500 companies
Issuer Fidelity Main
Theme Broad innovation and megatrends Broad innovation and megatrends
In the S&P 500 21.8% 50.3%
Active share vs the S&P 500 97.5% 91.6%
In the Nasdaq-100 5.1% 29.4%
Holdings 72 87
Top ten, share of the fund 33.2% 26.9%
Expense ratio 0.50% 0.79%
Fee for the differing part 0.51% 0.86%
Total return, 1 year +27.4% −3.1%
vs its benchmark not measured −18.1 pts vs ACWI
Below its high −0.9% −15.9%
Net assets, FMED as of Sep 30, 2026 and TMAT as of Jul 31, 2026 $52m $237m

As of Nov 4, 2026. Source: ETFIQ.

3% of the two portfolios are the same securities at the same weight.

Alert

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
FMED

By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.

TMAT

By weight, 50% of TMAT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 92%. The top ten holdings are 27% of the fund across 87 positions, as filed for Jul 31, 2026. Over the year to Nov 4, 2026 the fund returned −3.1% with distributions reinvested against +15.0% for its benchmark, the MSCI ACWI Index Net, so a holder was behind by 18.1 pts. It sits 15.9% below its all-time high of Jun 30, 2026.

Questions people ask

Do FMED and TMAT hold the same stocks?
By their latest filings, 3% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, FMED or TMAT?
FMED has 22% of its weight in S&P 500 names and TMAT has 50%, so FMED differs more from the index.
Which is cheaper, FMED or TMAT?
FMED charges 0.50% a year and TMAT charges 0.79%, so FMED is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, FMED against TMAT, data as of Nov 4, 2026. https://etfiq.com/compare/themes/fmed-vs-tmat

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.